vimarsana.com

Page 30 - போது தி உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An Army of White Coats: Exploring the Implications of Cuban Medical Diplomacy

An Army of White Coats: Exploring the Implications of Cuban Medical Diplomacy 23.Dec.2020 9:00 AM . 9 min read There are 68 languages spoken in Kenya. Most people speak Swahili or English and at least one of many local mother tongues. In the streets of Nairobi, it is not uncommon to hear greetings in multitudes of different languages, from “ hey, how are you?” in English to “ jambo, habari gani?” in Swahili, including “ wĩmwega, ũhana atĩa?” in Kikuyu. Kenyans speak and understand many different languages Spanish, however, is not usually one of them. In the past few years, though, Kenyans have been hearing Spanish increasingly often, especially when seeking medical care. The introduction of a new language in Kenyan society may be surprising, but it is not a coincidence. Like many other countries in the world, Kenyans have seen Cuban doctors enter their health facilities and provide healthcare alongside their local counterparts since 2018 when the Cuban

Maldives on alert over new COVID-19 strain

Maldives on alert over new COVID-19 strain 21 December 2020, MVT 19:01 HEOC spokesperson and Health Protection Agency (HPA) s Medical Officer Dr Nazla Rafeeq speaks at a press conference. PHOTO/HEOC 21 December 2020, MVT 19:01 Health Emergency Operations Centre (HEOC) declared late Sunday that Maldives was on alert and working to enhance precautions, over the contagious new strain of the coronavirus detected in the United Kingdom last week. Speaking at the virtually held biweekly press conference, HEOC spokesperson and Health Protection Agency (HPA) s Medical Officer Dr Nazla Rafeeq assured that authorities were closely monitoring the situation of the new COVID-19 strain. We re working on strengthening the implementation of existing measures, as well as enhancing their scope , she said.

Moderna s coronavirus vaccine gets FDA emergency use authorization

US regulators have authorized a second coronavirus vaccine for emergency use.  This two-dose vaccine, developed by the biotech firm Moderna and the US National Institutes of Health, was about 94% effective at preventing COVID-19 in a large clinical trial. Moderna s vaccine is easier to store and transport than Pfizer s COVID-19 shot, which got US clearance a week ago. Moderna plans to deliver 20 million doses in the US by year s end.  The authorization is the latest achievement in a remarkable story of science and business for Moderna, a company that has surged in 2020 based off its COVID-19 success. The US Food and Drug Administration authorized Moderna s coronavirus shot for emergency use, making the two-dose vaccine the second to be cleared by US regulators. 

The US just authorised Moderna s coronavirus vaccine, making millions more doses available to help curb the pandemic

US regulators have authorised a second coronavirus vaccine for emergency use. This two-dose vaccine, developed by the biotech firm Moderna and the US National Institutes of Health, was about 94% effective at preventing COVID-19 in a large clinical trial. Moderna’s vaccine is easier to store and transport than Pfizer’s COVID-19 shot, which got US clearance a week ago. Moderna plans to deliver 20 million doses in the US by year’s end. The authorization is the latest achievement in a remarkable story of science and business for Moderna, a company that has surged in 2020 based off its COVID-19 success. The US Food and Drug Administration authorised Moderna’s coronavirus shot for emergency use, making the two-dose vaccine the second to be cleared by US regulators.

The US just authorized Moderna s coronavirus vaccine, making millions more doses available to help curb the pandemic

» The US just authorized Moderna s coronavirus vaccine, making millions more doses available to help curb the pandemic The US just authorized Moderna s coronavirus vaccine, making millions more doses available to help curb the pandemic Andrew DunnDec 19, 2020, 06:53 IST Moderna; Samantha Lee/Business Insider US regulators have authorized a second coronavirus vaccine for emergency use. This two-dose vaccine, developed by the biotech firm Moderna and the US National Institutes of Health, was about 94% effective at preventing COVID-19 in a large clinical trial. Moderna s vaccine is easier to store and transport than Pfizer s COVID-19 shot, which got US clearance a week ago. Moderna plans to deliver 20 million doses in the US by year s end.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.